BCI
NEO icon

Brinker Capital Investments’s NeoGenomics NEO Stock Holding History

Brinker Capital Investments’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,002
Closed -$226K – 1414
2021
Q3 		$226K Hold
5,002
– – ﹤0.01% 1225
2021
Q2 		$226K Buy
5,002
+10
+0.2% +$443 ﹤0.01% 1277
2021
Q1 		$241K Sell
4,992
-4,548
-48% -$237K ﹤0.01% 1112
2020
Q4 		$514K Buy
+9,540
New +$431K 0.01% 831

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brinker Capital Investments's NEO Position: Q4 2021 in Review

Brinker Capital Investments sold out of NeoGenomics (NEO) in Q4 2021, closing a stake of 5,002 shares — an estimated $226K sold.

Brinker Capital Investments first reported a position in NEO in Q4 2020 and held it in 4 quarters. The position peaked at $514K in Q4 2020. 307 funds tracked by Wall St. Rank hold NEO as of Q4 2021.

  • Brinker Capital Investments reported no remaining NeoGenomics position as of Q4 2021 after selling out during the quarter.
  • Brinker Capital Investments sold 5,002 NeoGenomics shares in Q4 2021, an estimated $226K.
  • Brinker Capital Investments first reported a position in NeoGenomics in Q4 2020 and held it in 4 quarters.
  • Brinker Capital Investments's NeoGenomics position peaked at $514K in Q4 2020.
  • 307 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2021.

Based on Brinker Capital Investments's 13F filing for Q4 2021, filed 8 Feb 2022.